Keywords: astrazeneca, hands, back, zd0473, rights, given, notice

AstraZeneca hands back ZD0473 rights

Article | 28 November 2001

Print This

AstraZeneca has given notice to Canada's AnorMED that it does not intendto continue development of the latter's anticancer drug, ZD0473, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in